Investing News
Life Style
Market News
Medical Use
Pharmaceutical
Products
Technology
The Market Buzz
Your Environment
Modena, Merk Cancer Vaccine Reduced Melanoma Recurrence by 44%
Moderna (NASDAQ: MRNA) has developed an experimental personalized melanoma vaccine, which along with Merck & Co’s blockbuster immunotherapy Keytruda cut the risk of the skin cancer’s reappearance or death...